Tag: advanced accelerator applications

January 29, 2018

Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera

Novartis (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug...
January 26, 2018

Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA

Advanced Accelerator Applications (NASDAQ:AAAP) a Novartis company and leader in nuclear medicine theragnostics, today announced that  it has received US Food...
January 22, 2018

Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period

Novartis (NYSE: NVS) announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase...
October 6, 2016

Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares

Advanced Accelerator Applications, an international specialist in Molecular Nuclear Medicine, today announced the pricing of an underwritten public offering of...
September 23, 2016

Life Science Sector Responds Favorably to US Federal Reserve Decision

The US Federal Reserve did not raise interest rates on September 21—and the life science sector, like other markets, has...
September 22, 2016

EMA Prematurely Announced Opinion on SomaKit TOC® Kit Application

Advanced Accelerator Applications (NASDAQ:AAAP) announced that the European Medicines Agency (EMA) prematurely notified the public and the company of its...
May 18, 2016

ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy

RUVO DI PUGLIA, Italy, May 18, 2016 (GLOBE NEWSWIRE) — ITEL, a leading manufacturer of medical imaging products and services,...